2020-2023 年期间日本一家接种过大量疫苗的医疗中心医护人员的 SARS-CoV-2 血清流行率

IF 4.8 4区医学

Human Vaccines & Immunotherapeutics Pub Date : 2024-04-15 DOI:10.1080/21645515.2024.2337984

Yan Yan, Kanami Ito, Hiroshi Fukuda, Shuko Nojiri, Wataru Urasaki, Takamasa Yamamoto, Yuki Horiuchi, Satoshi Hori, Kazuhisa Takahashi, Toshio Naito, Yoko Tabe

引用次数: 0

摘要

全世界都在研究感染引起的 SARS-CoV-2 血清流行率。在日本东京的顺天堂大学医院（JUH），我们一直在使用血清进行血清学研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

SARS-CoV-2 seroprevalence among healthcare workers in a highly vaccinated Japanese medical center from 2020–2023

Infection-induced SARS-CoV-2 seroprevalence has been studied worldwide. At Juntendo University Hospital (JUH) in Tokyo, Japan, we have consistently conducted serological studies using the blood res...

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY

自引率

8.30%

发文量

审稿时长

1 months

期刊介绍： (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.